Phathom Pharmaceuticals (PHAT)
(Delayed Data from NSDQ)
$18.43 USD
-0.29 (-1.55%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $18.50 +0.07 (0.38%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-1.57 | 0.00% |
Earnings Summary
For their last quarter, Phathom Pharmaceuticals (PHAT) reported earnings of -$1.25 per share, missing the Zacks Consensus Estimate of -$1.20 per share. This reflects a negative earnings surprise of 4.17%. Look out for PHAT's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$1.57 per share, reflecting a year-over-year decrease of 106.58%.
Earnings History
Price & Consensus
Zacks News for PHAT
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates
PHAT: What are Zacks experts saying now?
Zacks Private Portfolio Services